Jump to:
loading...| Preferred Name |
remogliflozin etabonate |
| Synonyms |
4-(4-isopropoxybenzyl)-1-isopropyl-5-methyl-1H-pyrazol-3-yl 6-O-(ethoxycarbonyl)-beta-D-glucopyranoside |
| ID |
http://purl.bioontology.org/ontology/MESH/C532127 |
| altLabel |
4-(4-isopropoxybenzyl)-1-isopropyl-5-methyl-1H-pyrazol-3-yl 6-O-(ethoxycarbonyl)-beta-D-glucopyranoside |
| cui |
C2605528 |
| HM |
D005960 D011720 |
| Inverse of RB |
TR0QT6QSUL |
| isa | |
| Mapped to | |
| MDA |
20081007 |
| MeSH Frequency |
24 |
| MMR |
20180924 |
| notation |
C532127 |
| PA |
D000077203 |
| prefLabel |
remogliflozin etabonate |
| SC |
1 |
| Scope Statement |
orally administered hypoglycemic agent; structure in first source |
| SRC |
J Pharmacol Exp Ther 2008 Oct;327(1):268-76 |
| TERMUI |
T728267 T000937614 |
| TH |
NLM (2008) NLM (2017) FDA SRS (2013) INN (19XX) |
| tui |
T109 |